menu
    • menu

    Company profile for Emerald Health Therapeutics

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Emerald Health Therapeutics, Inc. is committed to creating new consumer experiences with recreational and wellness-oriented cannabis products. With an emphasis on innovation and production excellence, Emerald has built a platform of distinct operating assets designed to uniquely serve the Canadian marketplace and international opportunities. These assets, all in full production, include: Pure Sunfarms, its joint venture (4...
    Emerald Health Therapeutics, Inc. is committed to creating new consumer experiences with recreational and wellness-oriented cannabis products. With an emphasis on innovation and production excellence, Emerald has built a platform of distinct operating assets designed to uniquely serve the Canadian marketplace and international opportunities. These assets, all in full production, include: Pure Sunfarms, its joint venture (42.6% ownership) in British Columbia, with its 1.1 million square foot Delta 3 greenhouse operation producing high quality, affordably priced

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Emerald Health TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Emerald Health Therapeutics 800 West Pender Ave Vancouver, BC
    Telephone
    Telephone
    (800) 757 3536
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://emeraldhealth.ca/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Emerald Health Therapeutics CFO Jenn Hepburn to step down
    Emerald Health Therapeutics CFO Jenn Hepburn to step down

    10 Sep 2021

    // SEEKINGALPHA

    https://seekingalpha.com/pr/18468531-emerald-health-therapeutics-announces-chief-financial-officer-transition

    SEEKINGALPHA
    10 Sep 2021
    Share Share
    Emerald Health Pharma starts Activities for Initiation of Ph2 Clinical Study
    Emerald Health Pharma starts Activities for Initiation of Ph2 Clinical Study

    08 Mar 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/fr/news-release/2021/03/08/2188735/0/en/Emerald-Health-Pharmaceuticals-Starts-Activities-for-Initiation-of-Phase-2-Clinical-Study-in-Multiple-Sclerosis.html

    GLOBENEWSWIRE
    08 Mar 2021
    Share Share
    Emerald Health Pharmaceuticals Initiates Ph2 Clinical Study in SS
    Emerald Health Pharmaceuticals Initiates Ph2 Clinical Study in SS

    31 Mar 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/03/31/2009493/0/en/Emerald-Health-Pharmaceuticals-Initiates-Phase-2-Clinical-Study-in-Systemic-Sclerosis.html

    GLOBENEWSWIRE
    31 Mar 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search